P2RX5 and leukemia: Any possible utility in knowing this restricted pattern of P2X5 mRNA expression in the immune system lies in promoting the graft-versus-leukaemia reaction following stem cell implantation, where donor-derived cytotoxic T-lymphocytes can eliminate malignant leukaemic cells decorated by a P2X5-linked antigen in the recipient [19, 20].